Epitope Engineered Hematopoietic Stem and Progenitor Cells to Enable CAR-T Cell Immunotherapy for Acute Myeloid Leukemia

被引：0

作者：

Casirati, Gabriele ^{[1
,2
,3
]}

Cosentino, Andrea ^{[1
,4
,5
]}

Mucci, Adele ^{[1
,6
]}

Zabala, Iraxte Ugarte ^{[1
,7
]}

Mahmoud, Mohammed S. ^{[1
,8
]}

Brendel, Christian ^{[9
,10
]}

Rambaldi, Alessandro ^{[11
,12
]}

Ritz, Jerome ^{[13
,14
]}

Armstrong, Scott A. ^{[15
]}

Genovese, Pietro ^{[1
,3
,16
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Univ Milano Bicocca, Milan, Italy

[3] Boston Childrens Hosp, Boston, MA USA

[4] Univ Milan, Osped Papa Giovanni XXIII, Bergamo, Italy

[5] Boston Children Hosp, Boston, MA USA

[6] Boston Children Hosp, Pediat Oncol, Boston, MA USA

[7] German Canc Res Ctr DFKZ, Heidelberg, Germany

[8] Fayoum Univ, Fac Sci, Zool Dept, Al Fayyum, Egypt

[9] Harvard Med Sch, Hematol Oncol, Boston, MA 02115 USA

[10] Harvard Med Sch, Dana Farber Boston Childrens Canc & Blood Disorde, Gene Therapy Program, Boston, MA 02115 USA

[11] ASST Papa Giovanni XXIII, Hematol, Bergamo, Italy

[12] Univ Milan, Dept Oncol & Hematol, Milan, Italy

[13] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[14] Harvard Med Sch, Dept Med, Boston, MA 02115 USA

[15] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA

[16] Harvard Med Sch, Boston, MA 02115 USA

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-167285

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：2

共 50 条

[41] DONOR-DERIVED CAR-T CELLS FOR THE TREATMENT OF RELAPSED ACUTE B-LYMPHOBLASTIC LEUKEMIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Deng, Lei
Yu, Xiaolin
Song, Xiaocheng
Guan, Rui
Shao, Yan
Li, Wenjun
Zhou, Fang
BONE MARROW TRANSPLANTATION, 2024, 59 : 47 - 48
[42] Epitope prime editing shields hematopoietic cells from CD123 immunotherapy for acute myeloid leukemia
Ji, Rui-Jin
Cao, Guo-Hua
Zhao, Wei-Qiang
Wang, Mu-Yao
Gao, Pan
Zhang, Yi-Zhou
Wang, Xue-Bin
Qiu, Hou-Yuan
Chen, Di-Di
Tong, Xiao-Han
Duan, Min
Yin, Hao
Zhang, Ying
CELL STEM CELL, 2024, 31 (11)
[43] Immunotherapy of acute myeloid leukemia based on γδ T cells
Gertner-Dardenne, Julie
Fauriat, Cyril
Vey, Norbert
Olive, Daniel
ONCOIMMUNOLOGY, 2012, 1 (09) : 1614 - 1616
[44] Driving CAR T Stem Cell Targeting in Acute Myeloid Leukemia: The Roads to Success
Michelozzi, Ilaria M.
Kirtsios, Efstratios
Giustacchini, Alice
CANCERS, 2021, 13 (11)
[45] Between two kingdoms (CAR-T and hematopoietic stem cell transplantation)
Atrash, Shebli
TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (08): : 413 - 414
[46] The Role of T Cell Immunotherapy in Acute Myeloid Leukemia
Hao, Fang
Sholy, Christine
Wang, Chen
Cao, Min
Kang, Xunlei
CELLS, 2021, 10 (12)
[47] CAR-T immunotherapy: how will it change treatment for acute lymphoblastic leukemia and beyond?
Capitini, Christian M.
EXPERT OPINION ON ORPHAN DRUGS, 2018, 6 (10): : 563 - 566
[48] CAR-T cells for childhood and adult Acute Lymphoblastic Leukemia
Dourthe, Marie Emilie
Baruchel, Andre
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2018, 202 (07): : 1441 - 1451
[49] Thrombopoietin-based CAR-T cells demonstrate in vitro and in vivo cytotoxicity to MPL positive acute myelogenous leukemia and hematopoietic stem cells
Zoine, Jaquelyn T.
Prince, Chengyu
Story, Jamie Y.
Branella, Gianna M.
Lytle, Allison M.
Fedanov, Andrew
Alexander, Jordan S.
Porter, Christopher C.
Doering, Christopher B.
Spencer, H. Trent
Chandrakasan, Shanmuganathan
GENE THERAPY, 2022, 29 (05) : 247 - 258
[50] Thrombopoietin-based CAR-T cells demonstrate in vitro and in vivo cytotoxicity to MPL positive acute myelogenous leukemia and hematopoietic stem cells
Jaquelyn T. Zoine
Chengyu Prince
Jamie Y. Story
Gianna M. Branella
Allison M. Lytle
Andrew Fedanov
Jordan S. Alexander
Christopher C. Porter
Christopher B. Doering
H. Trent Spencer
Shanmuganathan Chandrakasan
Gene Therapy, 2022, 29 : 1 - 12

← 1 2 3 4 5 →